Aventra closed a $17.5M Series A to scale production of its Piranha guided glide bomb system from 35 units per month to 500 units monthly. The company has delivered over 400 units to US and NATO customers in under 12 months.
What's happening
- Aventra raised $17.5M in Series A funding led by Konvoy Ventures, with participation from Lavrock Ventures, Booz Allen Ventures, Sands Capital, Langford Industries, and Western Alliance Bank.
- The company will use proceeds to build Factory Zero facility in Virginia, increasing monthly Piranha production from 35 units to approximately 500 units.
- Aventra delivered over 400 Piranha systems to US and NATO customers within 12 months of emerging from stealth in October 2025 with a $3.5M seed round.
Why it matters
- Factory Zero addresses a critical production bottleneck for a low-cost guided munition system that glides 100 miles or more from 60,000-foot release altitude, presenting minimal air defense vulnerability.
- Scaling to 500 units monthly enables fulfillment of significant 2027 and 2028 order commitments from both US and NATO allies, expanding allied long-range strike capacity.
- The Piranha's $5 kg warhead and autonomous guidance replicate JDAM's transformation of unguided munitions at a fraction of traditional standoff munition costs, reshaping long-range strike economics.
Going deeper
- Piranha uses a custom-engineered munition loaded into an airframe and floated to stratospheric altitude, then dropped to glide to target under fully autonomous guidance with human override capability.
- Recent Army special mission unit demonstrations placed Piranhas within 3 meters of targets repeatedly, confirming accuracy for precision strike at low cost.
- The stratospheric launch point renders Piranha difficult to intercept with short-range air defense systems, creating an asymmetric air defense problem for adversaries.
Financial impact
- Series A funding increases Aventra's cash reserves by $17.5M to support Factory Zero capex and working capital for 2027-2028 production ramp; timing places revenue recognition across fiscal 2027 and 2028.
- Doubled production revenue in 2026 (post-seed) will accelerate as deliveries scale from current 35 monthly baseline, with significant order backlog for 2027 and material 2028 commitments.
- Factory Zero capex will flow through the balance sheet as property, plant and equipment, with depreciation beginning once facility becomes operational in late 2026 or early 2027.
The intrigue
- Aventra's munition partner remains undisclosed, raising questions about supply chain resilience and whether custom-munition production can scale alongside airframe assembly to hit 500-unit monthly targets.
- Factory Zero is described as a stepping stone to a larger campus planned for 2029, suggesting the startup anticipates demand growth beyond current 2028 order visibility.
The fine print
- Aventra's commercial channels split between US government and NATO customers, creating cross-border export compliance dependencies for a munitions product.
- Factory Zero production rate of 500 units monthly assumes supply chain maturity for the custom munition and component sourcing; any supplier delays could limit ramp timeline.